Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) Act 2006
18Application and modification of Repatriation Pharmaceutical Benefits Scheme
Start here
Get a plain-English read of 18
Turn the raw legal text into a practical explanation grounded in Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) Act 2006.
18 Application and modification of Repatriation Pharmaceutical Benefits Scheme
(1) The Repatriation Pharmaceutical Benefits Scheme, or, if that scheme has been modified under this section, that scheme as so modified, applies to the provision of pharmaceutical benefits in connection with treatment of eligible persons. (2) The Commission may, in writing, prepare modifications of the Repatriation Pharmaceutical Benefits Scheme in its application for the purposes of this Act. (3) Without limiting subsection (2), the modifications may specify classes of eligible persons for whom: (a) pharmaceutical benefits; or (b) pharmaceutical benefits of a kind specified in the instrument; or (c) pharmaceutical benefits included in a class of pharmaceutical benefits specified in the instrument; will not be provided, or will not be provided in circumstances specified or described in the instrument. (4) The Commission may, in writing, prepare variations or revocations of the modifications at any time. (5) A modification, or a variation or revocation of a modification, has no effect unless the Minister has, in writing, approved the instrument making the modification, variation or revocation. (6) A modification, or a variation or revocation of a modification, prepared by the Commission and approved by the Minister is a legislative instrument made by the Minister on the day on which the modification, variation or revocation is approved.